NANO-X IMAGING LTD Ordinary Shares NNOX
i
Market datapartial · fetched 2026-11-12T03:03:41.521Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-01-15
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:59:19.747278338Z
FundamentalsAlpha Vantage · unavailable
NANO-X IMAGING LTD Ordinary Shares options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 2.24 | 267.7% | 511.8% | 0.52 | 490.5% | 64.1% |
| 25Δ | 1.85 | 239.4% | 408.0% | 0.57 | 464.4% | 58.6% |
| 30Δ | 1.46 | 211.1% | 304.2% | 0.62 | 438.3% | 53.0% |
| 35Δ | 1.07 | 182.8% | 200.4% | 0.67 | 412.1% | 47.4% |
| 40Δ | 0.68 | 154.6% | 96.6% | 0.73 | 386.0% | 41.9% |
| 45Δ | 0.78 | 359.8% | 36.3% | |||
| 50Δ | 0.83 | 333.7% | 30.7% | |||
| 55Δ | 0.88 | 307.5% | 25.2% | |||
| 60Δ | 0.93 | 281.4% | 19.6% | |||
| 65Δ | 0.98 | 255.2% | 14.0% | |||
| 70Δ | ||||||
| 75Δ | ||||||
| 80Δ | ||||||
20Δ
- Pseudo strike
- 2.24
- IV
- 267.7%
- B/E move
- 511.8%
- Pseudo strike
- 0.52
- IV
- 490.5%
- B/E move
- 64.1%
25Δ
- Pseudo strike
- 1.85
- IV
- 239.4%
- B/E move
- 408.0%
- Pseudo strike
- 0.57
- IV
- 464.4%
- B/E move
- 58.6%
30Δ
- Pseudo strike
- 1.46
- IV
- 211.1%
- B/E move
- 304.2%
- Pseudo strike
- 0.62
- IV
- 438.3%
- B/E move
- 53.0%
35Δ
- Pseudo strike
- 1.07
- IV
- 182.8%
- B/E move
- 200.4%
- Pseudo strike
- 0.67
- IV
- 412.1%
- B/E move
- 47.4%
40Δ
- Pseudo strike
- 0.68
- IV
- 154.6%
- B/E move
- 96.6%
- Pseudo strike
- 0.73
- IV
- 386.0%
- B/E move
- 41.9%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.78
- IV
- 359.8%
- B/E move
- 36.3%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.83
- IV
- 333.7%
- B/E move
- 30.7%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.88
- IV
- 307.5%
- B/E move
- 25.2%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.93
- IV
- 281.4%
- B/E move
- 19.6%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.98
- IV
- 255.2%
- B/E move
- 14.0%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Medical Devices
NPCE
NeuroPace, Inc. is a medical device company in the United States. The company is headquartered in Mountain View, California.
More →NVCR
NovoCure Limited, an oncology company, is engaged in the development, manufacture and marketing of Optune for the treatment of a variety of solid tumors. The company is…
More →OFIX
Orthofix Medical Inc. is a medical device and biological products company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. The company is…
More →OM
Description unavailable
More →OWLT
Description unavailable
More →PACB
Description unavailable
More →